Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - lamotrigine - dispersible/chewable tablets - lamotrigine 200 mg - lamotrigine - lamotrigine - epilepsyadults and adolescents aged 13 years and above- adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.- seizures associated with lennox-gastaut syndrome. lamictal is given as adjunctive therapy but may be the initial antiepileptic drug (aed) to start with in lennox-gastaut syndrome.• children and adolescents aged 2 to 12 years- adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome.- monotherapy of typical absence seizures.bipolar disorder• adults aged 18 years and above- prevention of depressive episodes in patients with bipolar i disorder who experience predominantly depressive episodes (see section 5.1).lamictal is not indicated for the acute treatment of manic or depressive episodes.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - lamotrigine - dispersible/chewable tablets - lamotrigine 2 mg - lamotrigine - lamotrigine - epilepsyadults and adolescents aged 13 years and above- adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.- seizures associated with lennox-gastaut syndrome. lamictal is given as adjunctive therapy but may be the initial antiepileptic drug (aed) to start with in lennox-gastaut syndrome.• children and adolescents aged 2 to 12 years- adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome.- monotherapy of typical absence seizures.

Israel - English - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - chewable tablets - montelukast as sodium 5 mg - montelukast - montelukast - singulair 5 mg is indicated in adult and pediatric patients 6 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms of the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.because the benefits of singulair may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see warnings and precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.

Israel - English - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - chewable tablets - montelukast as sodium 4 mg - montelukast - montelukast - singulair is indicated in pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.because the benefits of singulair may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see warnings and precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.

Malta - English - Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - magnesium trisilicate, aluminium hydroxide - chewable tablet - magnesium trisilicate 500 mg aluminium hydroxide 250 mg - drugs for acid related disorders

Israel - English - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 1000 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Israel - English - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 112.5 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Israel - English - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 1400 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Israel - English - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 250 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Israel - English - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 500 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.